Clearside Biomedical Inc (CLSD)
1.31
-0.01
(-0.76%)
USD |
NASDAQ |
May 03, 14:01
Clearside Biomedical Revenue (Quarterly): 6.345M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 6.345M |
September 30, 2023 | 0.859M |
June 30, 2023 | 1.018M |
March 31, 2023 | 0.004M |
December 31, 2022 | 0.33M |
September 30, 2022 | 0.266M |
June 30, 2022 | 0.384M |
March 31, 2022 | 0.347M |
December 31, 2021 | 25.69M |
September 30, 2021 | 3.074M |
June 30, 2021 | 0.78M |
March 31, 2021 | 0.034M |
December 31, 2020 | 0.011M |
September 30, 2020 | 3.432M |
June 30, 2020 | 0.354M |
March 31, 2020 | 4.097M |
Date | Value |
---|---|
December 31, 2019 | 1.942M |
September 30, 2019 | 0.141M |
June 30, 2019 | 0.045M |
March 31, 2019 | 0.045M |
December 31, 2018 | 0.03M |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | 0.055M |
September 30, 2017 | 0.155M |
June 30, 2017 | 0.13M |
March 31, 2017 | 0.005M |
December 31, 2016 | 0.005M |
September 30, 2016 | 0.005M |
June 30, 2016 | 0.005M |
March 31, 2016 | 0.505M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.004M
Minimum
Mar 2023
25.69M
Maximum
Dec 2021
2.587M
Average
0.384M
Median
Jun 2022
Revenue (Quarterly) Benchmarks
Cassava Sciences Inc | -- |
Heron Therapeutics Inc | 34.23M |
Actinium Pharmaceuticals Inc | -- |
Karyopharm Therapeutics Inc | 33.75M |
Ocular Therapeutix Inc | 14.80M |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -4.832M |
Total Expenses (Quarterly) | 9.26M |
EPS Diluted (Quarterly) | -0.08 |
Enterprise Value | 69.71M |
Profit Margin (Quarterly) | -76.15% |
Earnings Yield | -40.46% |
Normalized Earnings Yield | -40.46 |